相关实验视频

Updated: Jun 17, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

晚期肺肉类瘤的异质性及其对免疫检查点抑制剂的有效性

Mengqing Xie¹, Tianqing Chu², Xiaorong Dong³

¹Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University, Shanghai, China.

European journal of cancer (Oxford, England : 1990)

|August 7, 2024

概括

免疫检查点抑制剂 (ICI) 对肺肉类瘤 (PSC) 有希望. 将ICI与抗血管性疗法结合使用可能会改善晚期PSC患者的治疗结果.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
基因组学就是基因组学.

背景情况:

肺肉类瘤 (PSC) 是一种罕见的非小细胞肺癌亚型.
免疫检查点抑制剂 (ICI) 已在非小细胞肺癌中表现出有效性,但在PSC中尚未得到充分研究.

研究的目的:

评估ICI在先进PSC中的有效性.
调查公共服务中心ICI响应的潜在机制.

主要方法:

对113名晚期PSC患者进行了多中心回顾性研究,这些患者接受了ICI治疗.
在预处理样本上进行整体外组测序 (WES) 和整体转录组测序.

主要成果:

无进展生存期 (PFS) 的中位数为8.77个月.
与ICI和抗血管原剂的联合治疗显著改善了PFS (p=0.04).
高TNFα信号和糖解基因表达与更好的预后相关.

结论:

国际投资基金表明,对先进的公共服务公司来说,有前途的好处.
与抗血管原剂的联合治疗可能代表PSC更有效的治疗策略.

关键词:

抗血管性疗法是一种抗血管性疗法.免疫治疗是一种免疫疗法.在NSCLCLC中,我们可以看到.这是一种罕见的瘤.瘤微环境是一个微环境.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.